Seeking Alpha

CLDX
Celldex Therapeutics, Inc

5/27/2012, 7:37 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CLDX Market Currents more »
CLDX Latest Transcript more »
Currently, there are no transcripts for CLDX.
CLDX Cramer more »
Currently, there are no Cramer articles on CLDX.
CLDX Instablog posts more »
  • BioQuanta S.A. Biotechnology From France To The World
    Mon, Apr 23 V.I.P. Comment!
  • ImmunoCellular Therapeutics: A Small But Interesting Theapeutic Cancer Vaccine Developer
    Mon, Aug 15, 2011 Smith On Stocks 1 Comment
  • Competitive Technologies (CTTC) to be on Good Morning America Tomorrow
    Mon, Mar 14, 2011 David Greene 1 Comment
  • Stock World Weekly
    Sun, Nov 21, 2010 Philip Davis 2 Comments
  • RXI's Orphan Drug & Fast Track Index (27 Stocks) => Rx Investors.com
    Tue, Nov 9, 2010 Justin M. Hall 1 Comment
Write a post on CLDX
CLDX StockTalks
CLDX vs. ETF Alternatives
Company Description

Celldex is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of... More